BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 18613260)

  • 21. Safety of green tea extracts : a systematic review by the US Pharmacopeia.
    Sarma DN; Barrett ML; Chavez ML; Gardiner P; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI; Low Dog T
    Drug Saf; 2008; 31(6):469-84. PubMed ID: 18484782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The state of adverse event reporting and signal generation of dietary supplements in Korea.
    Park KS; Kwon O
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):74-7. PubMed ID: 20074608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
    Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
    Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.
    Timbo BB; Chirtel SJ; Ihrie J; Oladipo T; Velez-Suarez L; Brewer V; Mozersky R
    Ann Pharmacother; 2018 May; 52(5):431-438. PubMed ID: 29171279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants.
    Ehrenpreis ED; Sifuentes H; Ehrenpreis JE; Smith ZL; Marshall ML
    Expert Opin Drug Saf; 2012 Mar; 11(2):177-83. PubMed ID: 22316142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety assurances for dietary supplements policy issues and new research paradigms.
    Basch EM; Servoss JC; Tedrow UB
    J Herb Pharmacother; 2005; 5(1):3-15. PubMed ID: 16093231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary supplements: a call to action.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):330-2. PubMed ID: 21133740
    [No Abstract]   [Full Text] [Related]  

  • 28. The Toxic Exposure Surveillance System (TESS): risk assessment and real-time toxicovigilance across United States poison centers.
    Watson WA; Litovitz TL; Belson MG; Wolkin AB; Patel M; Schier JG; Reid NE; Kilbourne E; Rubin C
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):604-10. PubMed ID: 16023159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety of niacin in the US Food and Drug Administration adverse event reporting database.
    Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2008 Apr; 101(8A):9B-13B. PubMed ID: 18375244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FDA drug safety surveillance program: adverse event reporting trends.
    Weiss-Smith S; Deshpande G; Chung S; Gogolak V
    Arch Intern Med; 2011 Mar; 171(6):591-3. PubMed ID: 21444854
    [No Abstract]   [Full Text] [Related]  

  • 33. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
    Hauben M; Reich L; Gerrits CM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary supplement adverse events: report of a one-year poison center surveillance project.
    Haller C; Kearney T; Bent S; Ko R; Benowitz N; Olson K
    J Med Toxicol; 2008 Jun; 4(2):84-92. PubMed ID: 18570167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of USP botanical dietary supplement monographs, 1995-2005.
    Schiff PL; Srinivasan VS; Giancaspro GI; Roll DB; Salguero J; Sharaf MH
    J Nat Prod; 2006 Mar; 69(3):464-72. PubMed ID: 16562859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: assessing the safety of dietary supplements.
    Bent S
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):958-60. PubMed ID: 17705239
    [No Abstract]   [Full Text] [Related]  

  • 37. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS).
    Bronstein AC; Spyker DA; Cantilena LR; Green J; Rumack BH; Heard SE
    Clin Toxicol (Phila); 2007 Dec; 45(8):815-917. PubMed ID: 18163234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seizures reported in association with use of dietary supplements.
    Haller CA; Meier KH; Olson KR
    Clin Toxicol (Phila); 2005; 43(1):23-30. PubMed ID: 15732443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of illness associated with poisonings of public health significance.
    Wolkin AF; Patel M; Watson W; Belson M; Rubin C; Schier J; Kilbourne EM; Crawford CG; Wattigney W; Litovitz T
    Ann Emerg Med; 2006 Feb; 47(2):170-6. PubMed ID: 16431230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.